Alison J Moskowitz
Overview
Explore the profile of Alison J Moskowitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
101
Citations
2163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Torka P, Feldman T, Savage K, Ganesan N, Drill E, Hancock H, et al.
J Clin Oncol
. 2024 Dec;
43(8):985-993.
PMID: 39661923
Purpose: We conducted a phase I/II study evaluating nivolumab plus doxorubicin, vinblastine, dacarbazine (N-AVD) as frontline therapy for treatment-naïve older adults (OA) with classical Hodgkin lymphoma (cHL; ClinicalTrials.gov identifier: NCT03033914)....
2.
Kumar A, Soumerai J, Soumerai J, Abramson J, Barnes J, Caron P, et al.
Blood
. 2024 Oct;
145(5):497-507.
PMID: 39437708
TP53-mutant mantle cell lymphoma (MCL) is associated with poor survival outcomes with standard chemoimmunotherapy. We conducted a multicenter, phase 2 study of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in untreated patients...
3.
Goyal A, OLeary D, Dabaja B, Weng W, Zain J, Cutler C, et al.
Transplant Cell Ther
. 2024 Sep;
30(11):1047-1060.
PMID: 39222792
Mycosis fungoides (MF) and Sézary syndrome (SS) are the most common subtypes of cutaneous T-cell lymphoma (CTCL). While MF generally follows an indolent course, a subset of patients will experience...
4.
Eren O, Stuver R, Zhou T, Zaidinski M, Moskowitz A, Horwitz S, et al.
Genes Chromosomes Cancer
. 2024 Aug;
63(6):e23252.
PMID: 39133763
T-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive mature T-cell malignancy characterized by marked lymphocytosis, B symptoms, lymphadenopathy, and hepatosplenomegaly. There is no standard treatment approach, and in the...
5.
Epstein-Peterson Z, Drill E, Aypar U, Batlevi C, Caron P, Dogan A, et al.
Haematologica
. 2024 Aug;
109(8):2749-2752.
PMID: 39087412
No abstract available.
6.
7.
Lewis N, Petrova-Drus K, Sardana R, Huet S, Gao Q, Sethi S, et al.
Haematologica
. 2024 Jul;
110(2):475-480.
PMID: 39021226
No abstract available.
8.
Luttwak E, Moskowitz A
Curr Opin Oncol
. 2024 Jul;
36(5):346-352.
PMID: 39007229
Purpose Of Review: Historically, salvage chemotherapy followed by high-dose chemotherapy and autologous stem cell transplant (HDT/ASCT) was the mainstay approach for relapsed or refractory classic HL. The emergence of novel...
9.
Stuver R, Dusza S, Epstein-Peterson Z, Ghione P, Horwitz S, Johnson W, et al.
J Eur Acad Dermatol Venereol
. 2024 May;
39(2):e114-e117.
PMID: 38818876
No abstract available.
10.
Johnson W, Epstein-Peterson Z, Ganesan N, Pak T, Chang T, Dao P, et al.
Haematologica
. 2024 May;
109(9):2998-3003.
PMID: 38752279
No abstract available.